5-hydroxymethylcytosine has been researched along with Lymph Node Metastasis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, M; Cui, M; Cui, X; Huang, C; Jiang, J; Jin, F; Li, Q; Liang, ZY; Liu, Y; Niu, Y; Qian, J; Sun, L; Tong, WM; Wang, X; Wu, HW; Wu, SL; Yu, X; Yuan, F; Zhang, X | 1 |
| Akazawa, Y; Hayashi, T; Murakami, T; Nagahara, A; Saito, T; Tsuyama, S; Ueyama, H; Watanabe, S; Yanai, Y; Yao, T; Yatagai, N | 1 |
| Balzer, BL; Essner, R; Frishberg, DP; Huynh, CAT; Shon, W; Siref, AB | 1 |
| Granter, SR; Guo, W; Laga, AC; Lee, JJ; Lian, CG; Murphy, GF; Saavedra, AP; Xu, S; Zhan, Q | 1 |
| Li, PL; Wang, TZ; Zhang, LY; Zhang, XC | 1 |
| Burns, KH; Rodić, N; Sharma, R; Taube, JM; Zampella, J | 1 |
| Chen, Z; Guo, L; He, J; Li, Y; Luo, M; Shi, X | 1 |
1 review(s) available for 5-hydroxymethylcytosine and Lymph Node Metastasis
| Article | Year |
|---|---|
Decreased 5-hydroxymethylcytosine levels correlate with cancer progression and poor survival: a systematic review and meta-analysis.
Topics: 5-Methylcytosine; Cytosine; DNA Methylation; Humans; Lymphatic Metastasis; Neoplasms; Prognosis | 2017 |
6 other study(ies) available for 5-hydroxymethylcytosine and Lymph Node Metastasis
| Article | Year |
|---|---|
Genome-wide 5-Hydroxymethylcytosine Profiling Analysis Identifies MAP7D1 as A Novel Regulator of Lymph Node Metastasis in Breast Cancer.
Topics: 5-Methylcytosine; Breast Neoplasms; Epigenomics; Female; Humans; Lymphatic Metastasis; Microtubule-Associated Proteins; Mixed Function Oxygenases; Proto-Oncogene Proteins | 2021 |
TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation.
Topics: 5-Methylcytosine; Adenocarcinoma; Aged; Aged, 80 and over; Ataxia Telangiectasia Mutated Proteins; Biomarkers, Tumor; Cell Differentiation; DNA Methylation; Female; Gene Silencing; Humans; Loss of Heterozygosity; Lymphatic Metastasis; Male; Middle Aged; Mixed Function Oxygenases; Mutation; Neoplasm Staging; Promoter Regions, Genetic; Proto-Oncogene Proteins; Stomach Neoplasms; Treatment Outcome; Tumor Suppressor Protein p53 | 2019 |
Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimen.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Diagnosis, Differential; Humans; Immunohistochemistry; Lymphatic Metastasis; MART-1 Antigen; Melanoma; Melanoma, Cutaneous Malignant; Nevus, Pigmented; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Skin Neoplasms; Staining and Labeling | 2019 |
5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cytosine; Female; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nevus; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2015 |
Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer.
Topics: 5-Methylcytosine; Adult; Aged; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Case-Control Studies; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Prognosis; Proto-Oncogene Proteins; Survival Analysis | 2015 |
Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations.
Topics: 5-Methylcytosine; Cytosine; Diagnosis, Differential; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Melanocytes; Melanoma; Nevus, Pigmented; Skin Neoplasms; Tissue Array Analysis | 2015 |